Closure of Trading Window for the period ending on 31.03.2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical has informed the exchange that its trading window will remain closed from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and financial year ending March 31, 2026. The restriction applies to all designated persons, their immediate relatives, and connected persons covered under the company's insider trading code. A board meeting will be scheduled separately to consider and approve the audited results, with a separate intimation to follow. This is a routine compliance filing under SEBI's insider trading regulations ahead of the annual results announcement.
This is a standard regulatory filing with no direct impact on stock price. However, it signals that audited FY26 results are imminent, and investors should watch for the upcoming board meeting announcement and results declaration for any material information.